Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC

MLA

Ying-xia Hao, et al. “Clinical Effects of Apatinib Combined with DOS Neoadjuvant Chemotherapy Regimen in Neoadjuvant Chemotherapy for LAGC.” Pakistan Journal of Medical Sciences, vol. 37, no. 7, Mar. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9e4b71641f869beff61d14105639d6b0&authtype=sso&custid=ns315887.

APA

Ying-xia Hao, Peng-zhe Zhou, Lei Gao, & Wei Wu. (2021). Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC. Pakistan Journal of Medical Sciences, 37(7).

Chicago

Ying-xia Hao, Peng-zhe Zhou, Lei Gao, and Wei Wu. 2021. “Clinical Effects of Apatinib Combined with DOS Neoadjuvant Chemotherapy Regimen in Neoadjuvant Chemotherapy for LAGC.” Pakistan Journal of Medical Sciences 37 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9e4b71641f869beff61d14105639d6b0&authtype=sso&custid=ns315887.